Literature DB >> 6949485

Reversible acute renal failure from combined triamterene and indomethacin: a study in healthy subjects.

L Favre, P Glasson, M B Vallotton.   

Abstract

As part of a study on the interaction between diuretics and renal prostaglandins, four healthy medical students receiving indomethacin for 8 days were also given triamterene for 3 days. Whereas renal function was initially normal in all four subjects, creatinine clearance decreased in two by 62% and 72% after concomitant administration of the two drugs, and was only restored to normal after 4 weeks. In control periods when triamterene or indomethacin was given alone renal function was preserved in all subjects. Urinary prostaglandin E2 was stimulated by triamterene and inhibited by indomethacin in all four subjects; both changes were more marked in the two sensitive subjects. Thus prostaglandin inhibition by indomethacin may unmask triamterene toxicity and contribute to the pathogenesis of the renal failure observed in sensitive subjects. As alternative therapy is readily available, avoidance of this potentially nephrotoxic association is recommended.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6949485     DOI: 10.7326/0003-4819-96-3-317

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

1.  Acute effects of the anti-inflammatory cyclooxygenase-2 selective inhibitor, flosulide, on renal plasma flow and glomerular filtration rate in rats.

Authors:  A Turull; C Piera; J Queralt
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  A review of non-steroidal anti-inflammatory drugs.

Authors:  D Rosenbloom; M A Craven
Journal:  Can Fam Physician       Date:  1983-11       Impact factor: 3.275

3.  Bartter's syndrome, nephrocalcinosis and renal insufficiency.

Authors:  A Pierratos; R A Couture; P J Hierlihy; R C Bell; D Z Levine
Journal:  CMAJ       Date:  1989-11-15       Impact factor: 8.262

Review 4.  Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure.

Authors:  J Feenstra; D E Grobbee; A Mosterd; B H Stricker
Journal:  Drug Saf       Date:  1997-09       Impact factor: 5.606

Review 5.  Interactions of NSAIDs with diuretics and beta-blockers mechanisms and clinical implications.

Authors:  J Webster
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

Review 6.  The elderly patient. A special case for diuretic therapy.

Authors:  D E Hyams
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 7.  Effects of non-narcotic analgesics on the kidney.

Authors:  P Kincaid-Smith
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 8.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 9.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

Review 10.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.